FP-011

N/A

Report date: 2025/04/28 14:59:29

Base Information

Drug NameFP-011
Drug Alias NameFP-011
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody
Mechanisms of ActionAnti-T cell immunoglobulin and ITIM domainsAnti-Transmembrane protein PVRIGAnti-PD-1 +[4] 
TargetsT cell immunoglobulin and ITIM domainsTransmembrane protein PVRIGProgrammed cell death protein 1 +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangdong Fapon Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Fapon Biopharma Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A